Skip to main content

Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.04
-0.96 (-0.45%)
AAPL  266.06
+1.88 (0.71%)
AMD  213.84
+0.00 (0.00%)
BAC  50.33
+0.50 (1.00%)
GOOG  307.49
-3.94 (-1.27%)
META  658.09
+9.91 (1.53%)
MSFT  389.00
+0.00 (0.00%)
NVDA  182.78
+5.59 (3.16%)
ORCL  147.88
+2.47 (1.70%)
TSLA  403.70
+1.19 (0.30%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.